Zobrazeno 1 - 10
of 113
pro vyhledávání: '"P. Putsathit"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-5 (2022)
Abstract Multidrug resistant (MDR) P. aeruginosa accounts for 35% of all P. aeruginosa isolated from respiratory samples of patients with cystic fibrosis (CF). The usefulness of β-lactam antibiotics for treating CF, such as carbapenems and later gen
Externí odkaz:
https://doaj.org/article/4785cfcf09d44b58a96d7bea30a7afd7
Autor:
Noel P. Pitcher, Jitendra R. Harjani, Yichao Zhao, Jianwen Jin, Daniel R. Knight, Lucy Li, Papanin Putsathit, Thomas V. Riley, Glen P. Carter, Jonathan B. Baell
Publikováno v:
ACS Omega, Vol 7, Iss 8, Pp 6737-6759 (2022)
Externí odkaz:
https://doaj.org/article/2cb2c9b176f449c28e66dba1e8d0cf30
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT There is growing evidence that shows Clostridium (Clostridioides) difficile is a pathogen of One Health importance with a complex dissemination pathway involving animals, humans, and the environment. Thus, environmental discharge and agricul
Externí odkaz:
https://doaj.org/article/a3d63e4f58404d21ba53c32e37fb61da
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp S3- (2022)
Externí odkaz:
https://doaj.org/article/e310e6316608416d8f89267e89bd0bd9
Autor:
Daniel Knight, Dr, Papanin Putsathit, Dr, Tom Riley, Professor, Jamie Wood, Dr, Siobhain Mulrennan, Clinical Professor, Anna S. Tai, Dr
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp S17- (2022)
Externí odkaz:
https://doaj.org/article/311f56ea04f24dde8a6cd22a8baeae4b
Autor:
Korakrit Imwattana, Daniel R. Knight, Brian Kullin, Deirdre A. Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V. Riley
Publikováno v:
Emerging Microbes and Infections, Vol 8, Iss 1, Pp 796-807 (2019)
ABSTRACTClostridium difficile ribotype (RT) 017 is an important toxigenic C. difficile RT which, due to a deletion in the repetitive region of the tcdA gene, only produces functional toxin B. Strains belonging to this RT were initially dismissed as n
Externí odkaz:
https://doaj.org/article/f3699d9edda646109ae796d32a636bf6
Publikováno v:
International Journal of Infectious Diseases, Vol 101, Iss , Pp 144- (2020)
Externí odkaz:
https://doaj.org/article/3498dfd13011408da515eb7285c87f04
Autor:
Muni Kumar Mahadari, Sreenu Jennepalli, Andrew J. Tague, Papanin Putsathit, Melanie L. Hutton, Katherine A. Hammer, Daniel R. Knight, Thomas V. Riley, Dena Lyras, Paul A. Keller, Stephen G. Pyne
Publikováno v:
Antibiotics, Vol 10, Iss 8, p 913 (2021)
Clostridioides (also known as Clostridium) difficile is a Gram-positive anaerobic, spore producing bacterial pathogen that causes severe gastrointestinal infection in humans. The current chemotherapeutic options are inadequate, expensive, and limited
Externí odkaz:
https://doaj.org/article/d7a93aa001934ee6ae056243ed218bbe
Autor:
Papanin Putsathit, Monthira Maneerattanaporn, Pipat Piewngam, Daniel R. Knight, Pattarachai Kiratisin, Thomas V. Riley
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 6, Iss 1, Pp 1-6 (2017)
Abstract Background Exposure to antimicrobials is the major risk factor associated with Clostridium difficile infection (CDI). Paradoxically, treatment of CDI with antimicrobials remains the preferred option. To date, only three studies have investig
Externí odkaz:
https://doaj.org/article/693319add81042c99576788e148abaa1